First Bancorp
Change company Symbol lookup
Select an option...
FBP First Bancorp
PTCT PTC Therapeutics Inc
ROKU Roku Inc
WORK Slack Technologies Inc
ARKW ARK Next Generation Internet ETF
SPOT Spotify Technology SA
GBTC Grayscale Bitcoin Trust (BTC)
ARKK ARK Innovation ETF
ARKG ARK Genomic Revolution ETF
ARKQ ARK Autonomous Technology & Robotics ETF
Go

Financials : Banks | Mid Cap Value
Based in Puerto Rico
Company profile

First BanCorp. is a financial holding company. As of December 31, 2016, the Company controlled two subsidiaries: FirstBank Puerto Rico (the Bank or FirstBank) and FirstBank Insurance Agency, Inc. (FirstBank Insurance Agency). It operates in six segments: Commercial and Corporate Banking, which consists of lending and other services; Consumer (Retail) Banking, which consists of consumer lending and deposit-taking activities; Mortgage Banking, which consists of the origination, sale, and servicing of a range of residential mortgage loan products and related hedging activities; Treasury and Investments, which consists of treasury and investment management functions; United States Operations, which consists of all banking activities conducted by FirstBank on the United States mainland, and Virgin Islands Operations, which consists of banking activities conducted by FirstBank in the United States Virgin Islands and British Virgin Islands, including retail and commercial banking services.

Closing Price
$10.13
Day's Change
-0.23 (-2.22%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.30
Day's Low
9.97
Volume
(Above Average)
Volume:
2,391,800

10-day average volume:
1,994,506
2,391,800

Mesoblast Limited Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm

7:42 pm ET November 18, 2020 (Globe Newswire) Print

Investors with losses are encouraged to contact the firm before December 7, 2020; click here to submit trade information

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Mesoblast Limited (NASDAQ: MESO) investors that acquired shares between April 16, 2019 and October 1, 2020. Investors have until December 7, 2020 to seek an active role in this litigation.

Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.

The investigation focuses on whether the company issued misleading and/or false statements and/or failed to disclose information pertinent to investors. On August 11, 2020 The FDA released briefing materials for the August 13, 2020, meeting of the Oncologic Drugs Advisory Committee. The meeting was to discuss the marketing application of Mesoblast for Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft-versus-host disease in pediatric patients. According to the FDA briefing documents, it was "unclear" if these study results are "relevant" to the proposed indication. On August 11, shares of Mesoblast fell by nearly 35% based on this news.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2020.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.

Admitted CA and NY Bar

lesley@portnoylaw.com

310-692-8883

www.portnoylaw.com

Attorney Advertising

https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg

https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.